Effects of S100A12 gene silencing on serum levels of anti-inflammatory/pro-inflammatory cytokines in septic rats through the ERK signaling pathway

Gyeji-tang water extract exerts anti-inflammatory activity through inhibition of ERK and NF-κB pathways in lipopolysaccharide-stimulated RAW 264.7 cells

(2016) Sae-Rom Yoo et al.   BMC Complementary and Alternative Medicine

Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsis

(2016) Ai-Ping Yang et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-κB pathways

(2014) Jin Hyun Kang et al.   IMMUNOLOGY

Location-specific expression of chemokines, TNF-α and S100 proteins in a teat explant model

(2014) Monique Lind et al.   Innate Immunity

Genistein inhibits pro-inflammatory cytokines in human mast cell activation through the inhibition of the ERK pathway

(2014) DONG HWAN KIM et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Neutrophil CD64 with Hematologic Criteria for Diagnosis of Neonatal Sepsis

(2013) Iris Streimish et al.   AMERICAN JOURNAL OF PERINATOLOGY

Biomarkers of sepsis

(2013) James D. Faix   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

(S)-tetrahydroisoquinoline alkaloid inhibits LPS-induced arachidonic acid release through downregulation of cPLA2 expression

(2013) Jong Min Choi et al.   MOLECULES AND CELLS

S100A12 Suppresses Pro-inflammatory, but Not Pro-Thrombotic Functions of Serum Amyloid A

(2013) Yuen Ming Chung et al.   PLoS One

S100A12 and Soluble Receptor for Advanced Glycation End Products Levels During Human Severe Sepsis

(2013) Ahmed Achouiti et al.   SHOCK

Crosstalk between Inflammation and Coagulation: The Lessons of Sepsis

(2012) Tom van der Poll et al.   Current Vascular Pharmacology

Evaluation of CD64 Expression on Neutrophils as an Early Indicator of Neonatal Sepsis

(2012) Sushant Soni et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The Pathogenesis of Sepsis

(2011) Deborah J. Stearns-Kurosawa et al.   Annual Review of Pathology-Mechanisms of Disease

A concise synthesis of viscolin, and its anti-inflammatory effects through the suppression of iNOS, COX-2, ERK phosphorylation and proinflammatory cytokines expressions

(2011) Guan-Jhong Huang et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome

(2010) Anastassios C Manolakis et al.   BMC GASTROENTEROLOGY

Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients

(2010) A. Nakashima et al.   Clinical Journal of the American Society of Nephrology

Significance of Measuring S100A12 and sRAGE in the Serum of Sepsis Patients with Postoperative Acute Lung Injury

(2010) Tomohiro Kikkawa et al.   DIGESTIVE SURGERY

MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis

(2009) Catalin Vasilescu et al.   PLoS One

Human S100A12: a novel key player in inflammation?

(2008) Jens Pietzsch et al.   AMINO ACIDS

Host–pathogen interactions in sepsis

(2007) Tom van der Poll et al.   LANCET INFECTIOUS DISEASES